Spelling suggestions: "subject:"mesenchymal step cells."" "subject:"esenchymal step cells.""
171 |
Terapeutický potenciál mezenchymálních kmenových buněk v myším experimentálním modelu / The therapeutic potential of mesenchymal stem cells in a mouse experimental modelHájková, Michaela January 2017 (has links)
Due to their immunomodulatory and regenerative potential, mesenchymal stem cells (MSCs) represent a promising therapeutic tool for cell-based therapy, organ transplantation or tissue engineering. To improve clinical applicability of MSCs, new methods to increase their delivery and efficacy have been tested in the latest years but the mechanism of observed alterations has not yet been described. In the present project we focused on studying the effect of several factors that can significantly affect the therapeutic success of MSC-based treatment. Initially, we analysed the therapeutic effect of MSCs applied locally on nanofiber scaffold with incorporated cyclosporine A (CsA) in a mouse model of allogeneic skin transplantation. Our results indicate that application of MSCs in the presence of CsA direct M1/M2 macrophage polarization towards regulatory phenotype. This phenotype switching is accompanied by decreased production of nitric oxide (NO) and interferon (IFN-) and increase production of interleukin 10 (IL-10), and may result in suppression of the local inflammatory reaction. The next goal of proposed study was to analyse the effect of the treatment based on MSCs combined with immunosuppressive drugs with different mechanism of action on the balance among distinct T cell subpopulations. We...
|
172 |
Exercise as an Adjuvant to Cartilage Regeneration TherapySmith, John Kelly 02 December 2020 (has links)
This article provides a brief review of the pathophysiology of osteoarthritis and the ontogeny of chondrocytes and details how physical exercise improves the health of osteoarthritic joints and enhances the potential of autologous chondrocyte implants, matrix-induced autologous chondrocyte implants, and mesenchymal stem cell implants for the successful treatment of damaged articular cartilage and subchondral bone. In response to exercise, articular chondrocytes increase their production of glycosaminoglycans, bone morphogenic proteins, and anti-inflammatory cytokines and decrease their production of proinflammatory cytokines and matrix-degrading metalloproteinases. These changes are associated with improvements in cartilage organization and reductions in cartilage degeneration. Studies in humans indicate that exercise enhances joint recruitment of bone marrow-derived mesenchymal stem cells and upregulates their expression of osteogenic and chondrogenic genes, osteogenic microRNAs, and osteogenic growth factors. Rodent experiments demonstrate that exercise enhances the osteogenic potential of bone marrow-derived mesenchymal stem cells while diminishing their adipogenic potential, and that exercise done after stem cell implantation may benefit stem cell transplant viability. Physical exercise also exerts a beneficial effect on the skeletal system by decreasing immune cell production of osteoclastogenic cytokines interleukin-1β, tumor necrosis factor-α, and interferon-γ, while increasing their production of antiosteoclastogenic cytokines interleukin-10 and transforming growth factor-β. In conclusion, physical exercise done both by bone marrow-derived mesenchymal stem cell donors and recipients and by autologous chondrocyte donor recipients may improve the outcome of osteochondral regeneration therapy and improve skeletal health by downregulating osteoclastogenic cytokine production and upregulating antiosteoclastogenic cytokine production by circulating immune cells.
|
173 |
Mesenchymal stromal cells in ischemic brain injuryBrooks, Beverly, Ebedes, Dominique, Usmani, Ahsan, Gonzales-Portillo, Joaquin Vega, Gonzales-Portillo, Daniel, Borlongan, Cesario V. 01 March 2022 (has links)
Ischemic brain injury represents a major cause of death worldwide with limited treatment options with a narrow therapeutic window. Accordingly, novel treatments that extend the treatment from the early neuroprotective stage to the late regenerative phase may accommodate a much larger number of stroke patients. To this end, stem cell-based regenerative therapies may address this unmet clinical need. Several stem cell therapies have been tested as potentially exhibiting the capacity to regenerate the stroke brain. Based on the long track record and safety profile of transplantable stem cells for hematologic diseases, bone marrow-derived mesenchymal stromal cells or mesenchymal stromal cells have been widely tested in stroke animal models and have reached clinical trials. However, despite the translational promise of MSCs, probing cell function remains to be fully elucidated. Recognizing the multi-pronged cell death and survival processes that accompany stroke, here we review the literature on MSC definition, characterization, and mechanism of action in an effort to gain a better understanding towards optimizing its applications and functional outcomes in stroke. / National Institutes of Health / Revisión por pares
|
174 |
Neural recovery after cortical injury: effects of MSC derived exosomes in the cervical spinal cordCalderazzo, Samantha 11 June 2019 (has links)
Stroke is the leading cause of long-term disability costing the United States (US) health care system 34 billion dollars. However, stem cell based therapies have been shown to improve recovery after cortical injury by enhancing neural recovery and modulating immune responses (Lambertsen, Finsen, & Clausen, 2018; Orczykowski et al., 2018; Stonesifer et al., 2017). Specifically, reorganization of the motor circuit at the level of the spinal cord has been shown to improve functional recovery after injury (Christoph Wiessner; Weidner et al., 2001; Lee et al., 2004; Zai et al., 2009). In our study we used a non-human primate (NHP) model to study the neural recovery after cortical injury similar to damage from an ischemic stroke in the motor cortex with or without a systemic treatment of mesenchymal stem cell derived (MSCd) exosomes. We find a robust recovery in motor function within the first few weeks after injury including improved grasp patterns and faster retrieval times during behavioral tasks. Additionally, assessment of the cervical spinal cord (CSC) reveals decreased levels of sprouting axons from ipsilesional corticospinal tract (CST) and MAP2+ synapses in the contralesional ventral horn at 14 weeks post-injury, which correlates with improved retrieval latencies. We hypothesize that MSCd exosomes may encourage an earlier switch to anti-inflammatory and repair processes that reduces secondary damage in the cortex resulting in earlier pruning of axon collaterals and reducing the need for compensatory mechanisms of the spinal cord at 14 weeks post injury.
|
175 |
Le rôle du système nerveux sensoriel dans l'orchestration de la formation osseuse, le remodelage et la régénération tissulaire / The role of sensory nervous system in the regulation of bone formation, remodeling, and repairSilva, Diana 21 December 2017 (has links)
Les progrès dans la compréhension de la biologie osseuse ont permis d’identifier le rôle du système nerveux sensoriel dans la formation osseuse, le remodelage et la régénération tissulaire. Cependant, le rôle précis du système nerveux sensoriel sur la l’ostéogénèse reste encore méconnu. La première partie de ce travail a été d’analyser le rôle des neurones du ganglion de la racine dorsale (DRG) sur la différenciation ostéoblastique des cellules souches mésenchymateuse (MSCs). Pour répondre à cette question, nous avons utilisé une plate-forme microfluidique, qui tente de mimer l’innervation sensorielle du tissu osseux. Dans la seconde partie de cette étude, nous avons cherché à mieux caractériser la sous-population de neurones DRG impliqués dans la régulation directe de la différenciation des MSCs vers le lignage ostéoblastique. En conclusion, l’ensemble des résultats permettent de montrer que: i) les neurones sensoriels ont un effet positif et direct sur la différenciation ostéoblastique des cellules ostéoprogénitrices, ii) la voie de signalisation Wnt/β-caténine est impliquée dans cette transduction du signal; iii) cet effet est principalement régulé par des neurones sensorimoteur, iv) qui peuvent induire la libération locale de facteurs neuroactifs. / Advances in the understanding of bone biology have identified the sensory nervous system as a critical regulator in the orchestration of bone formation, remodeling, and repair. However, the precise role of the sensory nervous system on bone tissue, particularly on osteoprogenitor cells, remains unknown. Firstly, we were interested in clarifying whether dorsal root ganglion (DRG) neurons would be able to induce the osteoblast differentiation by acting directly on mesenchymal stem cells (MSCs). Afterwards, we attempted to understand whether the canonical Wnt signaling pathway could be implicated in the DRG neurons-induced osteoblastogenesis. In the second part of this study, we aimed at better characterizing the subset of DRG neurons involved in the direct regulation of osteoblast differentiation from MSCs. In this work we provide several novel insights: i) we show that sensory neurons have a positive and direct effect on osteoblast differentiation of osteoprogenitor cells, ii) by activating the Wnt/β-catenin signaling pathway; and iii) we suggest that this effect is mainly regulated by sensorimotor neurons, iv) which possibly mediate the local release of neuroactive factors.
|
176 |
Rôle de la désensibilisation de CXCR4 dans l'homéostasie médullaire chez la souris / Role of Cxcr4 desensitization in the maintenance of bone marrow homeostasis in miceNguyen, Julie 20 November 2018 (has links)
Le couple CXCL12/CXCR4 joue un rôle essentiel dans le maintien de l’homéostasie des cellules souches et progéniteurs hématopoïétiques (CSPHs) et constitue un axe clé par lequel les niches et les CSPHs communiquent au sein de la moelle osseuse (MO). Des mutations hétérozygotes du gène CXCR4, qui tronquent le domaine C-terminal de la protéine et entraînent un défaut de désensibilisation homologue de CXCR4 et une hypersensibilité à CXCL12, ont été identifiées dans le Syndrome WHIM (SW), une immunodéficience rare caractérisée notamment par une lymphopénie. Les mécanismes sous-jacents de cette anomalie restaient inconnus. Grâce à un modèle murin porteur d’une mutation gain de fonction de Cxcr4 identifiée chez certains patients et phénocopiant la lymphopénie du SW, nous avons exploré la possibilité qu’un défaut de domiciliation, de différenciation ou d’expansion des CSPHs dans la MO soit à l’origine de la lymphopénie circulante. Nous avons mis en évidence que la désensibilisation de Cxcr4 régule la balance quiescence/cycle des CSHs à court terme ainsi que leur différenciation en progéniteurs multipotents et progéniteurs engagés vers le lignage lymphoïde. Nos travaux révèlent donc que la désensibilisation de Cxcr4 est requise à la différenciation lymphoïde des CSPHs et suggèrent que l’absence de ce processus soit à l’origine de la lymphopénie observée chez les souris mutantes et, par extrapolation, chez les patients. Ces altérations lymphoïdes impliquaient à la fois des défauts intrinsèques (CSPHs) et extrinsèques (stroma), ce qui nous a conduit à considérer l’impact de la mutation gain de fonction de Cxcr4 sur le stroma médullaire. Dans ce contexte, l’objectif principal de mon projet de thèse a consisté à investiguer à l’aide du modèle murin du SW le rôle de la désensibilisation de Cxcr4 dans le maintien des composantes mésenchymateuses au sein de la MO. Nos données ont permis de mettre en lumière que la désensibilisation de Cxcr4 est intrinsèquement requise à la régulation de l’équilibre quiescence/cycle des cellules souches mésenchymateuses (CSMs), ainsi qu’à la préservation de leur potentiel ostéogénique en contrôlant l'expression et la biodisponibilité de Cxcl12 de manière autocrine. Par conséquent, nos travaux suggèrent que les actions autocrines et paracrines de l’axe de signalisation Cxcl12/Cxcr4 au sein des CSMs régulent leur différenciation en ostéoblastes tout en contribuant au maintien des niches des CSPHs et au processus d’hématopoïèse. / The CXCL12/CXCR4 signaling axis plays an essential role in the maintenance of hematopoietic stem and progenitor cell (HSPC) homeostasis and constitutes a key pathway through which the niches and HSPCs communicate in the bone marrow (BM). Heterozygous gain-of-function mutations of CXCR4, which engender a truncated receptor and affect its homologous desensitization in response to CXCL12, have been reported in the WHIM Syndrome (WS); a rare immunodeficiency notably characterized by lymphopenia. The mechanisms underpinning this remain obscure. Using a mouse model harboring a naturally occurring WS-linked Cxcr4 gain-of-function mutation, we explored the possibility that the lymphopenia in WS arise from defects at the HSPC level in the BM. We showed that Cxcr4 desensitization is required for proper quiescence/cycling balance of short-term HSCs as well as their differentiation into multipotent progenitors and downstream lymphoid-biased progenitors. Thus, our results suggest that efficient Cxcr4 desensitization is critical for lymphoid differentiation of HSPCs, and its impairment is a key mechanism underpinning the lymphopenia observed in WS mice. The role of Cxcr4 desensitization in regulating such lympho-hematopoiesis process implicated both intrinsic and extrinsic properties, thus raising the question of the impact of a gain-of-Cxcr4-function mutation on BM stroma. Therefore, the main part of my PhD project was dedicated to evaluate using this relevant knock-in model the impact of Cxcr4 desensitization on maintenance of BM mesenchymal elements. We have found unexpectedly that such regulatory mechanism is intrinsically required for regulating quiescence/cycling balance of mesenchymal stem cells (MSCs) and preserving their osteogenic potential through the control of Cxcl12 expression and availability in an autocrine manner. Therefore, these findings support autocrine and paracrine actions of the Cxcl12/Cxcr4 signaling axis within MSCs to regulate osteoblast differentiation while contributing to HSPC niches and hematopoiesis.
|
177 |
The Mechanotransduction of Hydrostatic Pressure by Mesenchymal Stem CellsHosseini, Seyedeh Ghazaleh 12 1900 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Mesenchymal stem cells (MSCs) are responsive to mechanical stimuli that play an
essential role in directing their differentiation to the chondrogenic lineage. A better
understanding of the mechanisms that allow MSCs to respond to mechanical stimuli
is important to improving cartilage tissue engineering and regenerative medicine.
Hydrostatic pressure (HP) in particular is known to be a primary mechanical force in
joints. However, little is known about the underlying mechanisms that facilitate HP
mechanotransduction. Understanding the signaling pathways in MSCs in transducing
HP to a beneficial biologic response and their interrelationship were the focus of this
thesis. Studies used porcine marrow-derived MSCs seeded in agarose gel. Calcium ion Ca++ signaling, focal adhesion kinase (FAK) involvement, and sirtuin1 activity
were investigated in conjunction with HP application.
Intracellular Ca++ concentration was previously shown to be changed with HP
application. In our study a bioreactor was used to apply a single application of HP to the MSC-seeded gel structures and observe Ca++ signaling via live imaging of a fluorescent calcium indicator in cells. However, no fluctuations in Ca++ concentrations
were observed with 10 minutes loading of HP. Additionally a problem with the biore
actor design was discovered. First the gel was floating around in the bioreactor even
without loading. After stabilizing the gel and stopping it from floating, there were
still about 16 µm of movement and deformation in the system. The movement and
deformation was analyzed for the gel structure and different parts of the bioreactor.
Furthermore, we investigated the role of FAK in early and late chondrogenesis
and also its involvement in HP mechanotransduction. A FAK inhibitor was used on
MSCs from day 1 to 21 and showed a dose-dependent suppression of chondrogenesis.
However, when low doses of FAK inhibitor added to the MSC culture from day 21 to
42, chondrogenesis was not inhibited. With 4 hour cyclic HP, FAK phosphorylation
increased. The beneficial effect of HP was suppressed with overnight addition of the
FAK inhibitor to MSC medium, suggesting FAK involvement in HP mechanotransd
ucation by MSCs.
Moreover, sirtuin1 participation in MSC chondrogenesis and mechanotransduc
tion was also explored. The results indicated that overnight sirtuin1 inhibition in
creased chondrogenic gene expression (Agc, Col2, and Sox9) in MSCs. Additionally,
the activity of sirtuin1 was decreased with both 4 hour cyclic hydrostatic pressure
and inhibitor application. These two together demonstrated that sirtuin1 inhibition
enhances chondrogenesis.
In this research we have investigated the role of Ca++ signaling, FAK involvement,
and sirtuin1 activity in the mechanotransduction of HP in MSCs. These understand
ings about the mechanisms regulating the chondrogenesis with respect to HP could
have important implications for cartilage tissue engineering and regenerative studies.
|
178 |
Dynamic Control of Hydrogel Properties via Enzymatic ReactionsMoore, Dustin M. 05 1900 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Dynamic changes to the extracellular matrix (ECM) impact many cell fate pro-
cesses. The ECM can experience changes in sti ness as well as changes in composi-
tion in response to injury, development, and diseases. To better understand the role
that these dynamic processes have on the cells residing within the environment, re-
searchers have turned towards 4-dimensional (4D) hydrogel designs. These 4D hydro-
gels re-capitulate not only 3-dimensional (3D) matrix architectures, but also temporal
changes in the physicochemical properties. The goal of this thesis was to design a
unify chemistry (i.e., Sortase A (SrtA)-mediated transpeptidation) for dynamic tun-
ing hydrogel sti ness and the presence of bioactive ligands. The rst objective was
to establish a tunable and cytocompatible enzymatic scheme for softening cell-laden
hydrogels. Brie
y, the e ects of SrtA-mediated matrix cleavage were investigated us-
ing poly(ethylene glycol) (PEG)-peptide hydrogels crosslinked by SrtA-sensitive and
insensitive peptides. Initially, the e ects of various parameters with respect to cat-
alytic reactions of SrtA were characterized rheologically, including enzyme and sub-
strate concentrations, macromer content, peptide composition, and treatment time.
Gel moduli pre- and post-enzyme treatment were measured to verify SrtA-mediated
hydrogel softening. The cytocompatibility of SrtA-mediated gel softening system was
investigated using human mesenchymal stem cell (hMSC). Upon treatment with SrtA
and an oligoglycine substrate, encapsulated hMSCs exhibited extensive spreading in
comparison to those within statically sti matrices. The second objective was to es-
tablish a reversible ligand exchange system utilizing SrtA-mediated transpeptidation.
SrtA-sensitive pendant ligands were immobilized within PEG hydrogels, which were treated with SrtA and an oligoglycine substrate to a ord tunable removal of the pen-
dant ligand. Through measurement of the liberated pendant peptide concentration,
it was found that higher concentrations of SrtA or extending treatment times led
to higher ligand removal e ciency. Finally, the e ect of peptide ligand removal on
cell behaviors were evaluated using NIH 3T3 broblasts. Fibroblasts were culture
both on and within hydrogels containing SrtA-cleavable cell adhesion peptide. After
treatment, both conditions led to a decrease in broblast spreading in comparison
to non-treated gels. Overall, the utility of SrtA as versatile agent for controlling the
mechanical properties and the presence of biologically active components within a
hydrogel system was demonstrated. These systems could be further explored with natural-based materials to better mimic the physiological environment experienced
by cells.
|
179 |
Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model / ラット人工心肺モデルにおける卵膜由来間葉系幹細胞の投与は急性肺障害を改善するTaki, Tomofumi 23 March 2017 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20250号 / 医博第4209号 / 新制||医||1020(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 伊達 洋至, 教授 戸口田 淳也, 教授 開 祐司 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
180 |
Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon. / 非ウィルスベクターであるpiggyBac transposonを用いた挿入遺伝子の遺残のない肝細胞様細胞の作製Katayama, Hokahiro 24 July 2017 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第20605号 / 医博第4254号 / 新制||医||1023(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 川口 義弥, 教授 浅野 雅秀, 教授 中川 一路 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
Page generated in 0.058 seconds